Innovation
Obama Administration Wants to Eliminate References to Doha Declaration in UN Political Declaration on Non-Communicable Diseases
Submitted by Krista Cox on 10. September 2011 - 8:30The United States and the European Union are using a United Nations High Level Meeting on Non-Communicable Diseases (NCDs) to effectively renegotiate a landmark agreement on intellectual property rights and public health.
Jan 2009, Ranneberger reports on Kenya anti-counterfeit goods legislation
September 3, 2011
From KEI staff review of Wikileaks cables (http://keionline.org/wikileaks)
The following is a January 2009 cable written by Michael E. Ranneberger, the U.S. Ambassador to Kenya. The subject of the cable is: Kenya Passes Long Awaited Anti-counterfeit Goods Bill
http://cablegatesearch.net/cable.php?id=09NAIROBI86
Cable reference id: #09NAIROBI86Reference id aka Wikileaks id #186907 ???
Subject Kenya Passes Long Awaited Anti-counterfeit Goods Bill
Origin Embassy Nairobi (Kenya)
Federal Circuit decision in AMP v. USPTO results in three-way split in reasoning; 2-1 decision finds isolated DNA patentable
Submitted by Krista Cox on 29. July 2011 - 13:07It has been estimated that 1 out of every 8 women in the United States will develop invasive breast cancer during her lifetime. Although a diagnostic test exists to identify mutations on the BRCA1 and BRCA2 human genes, two genes associated with breast and ovarian cancer, many women are not afforded the opportunity to have testing done because Myriad Genetics holds exclusive rights over these genes.
KEI, MSF, Oxfam and PC provide follow up comments on USPTO humanitarian priority review voucher proposal
Submitted by Krista Cox on 13. July 2011 - 11:50USPTO is currently considering a pilot program to grant priority review vouchers as an incentive mechanism for technologies or licensing that responds to humanitarian needs. KEI, MSF, Oxfam and PC previously submitted comments on November 19, 2010 and provided additional comments on March 4, 2011 with UAEM.
Federal Circuit hears oral arguments on patent eligibility of DNA claims
Submitted by Krista Cox on 4. April 2011 - 10:41On Monday, April 4, 2011, a panel of three Federal Circuit judges heard oral arguments about the patentability of the BRCA 1/2 gene claims in American Molecular Pathology, et. al, v. U.S. Patent and Trademark Office, et. al.. The panel included Judge Lourie, Judge Bryson and Judge Moore. Gregory Castanias from Jones Day argued for Myriad's position, defending the DNA claims while Chris Hansen of the ACLU argued against the patentability of the claims. The U.S.
United States Patent and Trademark Office’s "Humanitarian Pilot Proposal." Comments by KEI, MSF, Oxfam, PC and UAEM
Submitted by James Love on 7. March 2011 - 13:21The USPTO is considering a pilot program to consider the benefits of providing a voucher for certain accelerated reviews of patent applications, as a reward for licensing patents for humanitarian uses. On March 2, 2011, Anne Guha provided a very useful summary of public comments on the proposal, which is available here: http://www.keionline.org/node/1074
Dec 9, 2009 Wikileaks documents related to the WHO EWG
Submitted by Malini Aisola on 21. January 2010 - 9:30On December 9, 2009, Wikileaks posted five sensitive documents related to the WHO Expert Working Group (EWG) on R&D Financing:
a non-public draft report of the WHO EWG a non-public Comparative Analysis done by the EWG the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) Overview of the EWG Comparative Analysis an IFPMA summary slide on the EWG Draft Report
The Bayh-Dole Act of 1980
The Bayh-Dole Act (or University and Small Business Patent Procedures Act) was originally enacted in 1980 as Public Law 96-517, and was amended in 1984 by Public Law 98-620. Among other things, the Bayh-Dole Act was designed to facilitate the patenting of U.S. government funded inventions by universities, other non-profit entities and businesses.
WHO at a crossroads on a mandate for an R&D Treaty
Submitted by Judit Rius on 21. May 2009 - 5:5121 May 2009
Today at the World Health Assembly (WHA) the US and EU are opposing that the WHO have a mandate on global research and development norms, including the possibility for Member States to negotiate at WHO a global biomedical R&D treaty.
Developing countries governments made very strong interventions this morning on this issue (among them India, Bolivia, Barbados, Suriname, Bangladesh, Ghana, Argentina, Venezuela, Nicaragua, Ecuador, Cuba and Jamaica) and are wondering where are the promises of multilateralism made by the new Obama administration.
WHA: Draft resolution to finish Plan of Action on Public Health, Innovation and Intellectual Property
Submitted by Judit Rius on 20. May 2009 - 3:19This morning a draft Resolution proposed by the Delegations of Canada, Chile, Iran (Islamic Republic), Japan, Libyan Arab Jamahiriya, Norway and Switzerland was distributed to the 62nd WHA as document A62/A/Conf.Paper No.4
If approved in its current form, the resolution will conclude the Plan of Action with the stakeholders, time frames and progress indicators proposed by the documents distributed by the WHO PHI secretariat this week.
